Home › Funds › TANAKA CAPITAL MANAGEMENT INC › CPRX
TANAKA CAPITAL MANAGEMENT INC position in CPRX
CATALYST PHARMACEUTICALS INC
TANAKA CAPITAL MANAGEMENT INC reported holding 113,418 shares of CPRX (CATALYST PHARMACEUTICALS INC) in its Q1 2026 13F filing — a position valued at US$2.8M, representing 4.69% of its reported portfolio and ranking #9 among its reported holdings. TANAKA CAPITAL MANAGEMENT INC has disclosed CPRX holdings in 8 of the last 11 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How TANAKA CAPITAL MANAGEMENT INC's CPRX position evolved
TANAKA CAPITAL MANAGEMENT INC first disclosed a stake in CPRX in Q3 2023 at 159,791 shares (US$1.9M). The position peaked in Q1 2025 at 151,893 shares, worth US$3.7M. Across 8 filings, TANAKA CAPITAL MANAGEMENT INC increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q1 2026) shows 113,418 shares valued at US$2.8M — a reduction of -1,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 159.79K | $1.87M | New |
| Q4 2023 | 154.43K | $2.60M | Reduce |
| Q3 2024 | 153.29K | $3.05M | Reduce |
| Q4 2024 | 153.29K | $3.20M | Hold |
| Q1 2025 | 151.89K | $3.68M | Reduce |
| Q3 2025 | 114.42K | $2.25M | Reduce |
| Q4 2025 | 114.42K | $2.67M | Hold |
| Q1 2026 | 113.42K | $2.81M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CPRX and 13F data
CPRX (CATALYST PHARMACEUTICALS INC) is a company whose sector is not yet classified in our data. 43 other funds we track also report a position in CPRX — the largest reported positions include GLAZER CAPITAL, LLC (US$113.2M), HBK INVESTMENTS L P (US$88.6M), NEXPOINT ASSET MANAGEMENT, L.P. (US$50.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CPRX
- GLAZER CAPITAL, LLC 3.60M sh · $113.24M · Q2 2026
- HBK INVESTMENTS L P 2.82M sh · $88.64M · Q2 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 1.60M sh · $50.37M · Q2 2026
- Polar Asset Management Partners Inc. 1.15M sh · $36.15M · Q2 2026
- WATER ISLAND CAPITAL LLC 933.82K sh · $29.35M · Q2 2026
- KENNEDY CAPITAL MANAGEMENT LLC 856.61K sh · $26.92M · Q2 2026
- Sagefield Capital LP 569.48K sh · $17.90M · Q2 2026
More on TANAKA CAPITAL MANAGEMENT INC
FAQ
How long has TANAKA CAPITAL MANAGEMENT INC held CPRX?
TANAKA CAPITAL MANAGEMENT INC has disclosed CPRX holdings in 8 of the last 11 reported quarters, going back to Q3 2023.
What is TANAKA CAPITAL MANAGEMENT INC's current position in CPRX?
As of Q1 2026, TANAKA CAPITAL MANAGEMENT INC holds 113.42K shares of CPRX (CATALYST PHARMACEUTICALS INC), valued at $2.81M, representing 4.69% of its reported portfolio and ranking #9.
Has TANAKA CAPITAL MANAGEMENT INC been buying or selling CPRX?
In the latest 13F filing (Q1 2026), TANAKA CAPITAL MANAGEMENT INC reduced its position in CPRX. The position peaked in Q1 2025 at 151.89K shares.
Which other funds hold CPRX?
Other major institutional holders of CPRX include GLAZER CAPITAL, LLC, HBK INVESTMENTS L P, NEXPOINT ASSET MANAGEMENT, L.P., among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.